Exact Mass: 566.2394804
Exact Mass Matches: 566.2394804
Found 261 metabolites which its exact mass value is equals to given mass value 566.2394804
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
PA(2:0/6 keto-PGF1alpha)
C25H43O12P (566.2492007999999)
PA(2:0/6 keto-PGF1alpha) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/6 keto-PGF1alpha), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 6-Keto-prostaglandin F1alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(6 keto-PGF1alpha/2:0)
C25H43O12P (566.2492007999999)
PA(6 keto-PGF1alpha/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(6 keto-PGF1alpha/2:0), in particular, consists of one chain of one 6-Keto-prostaglandin F1alpha at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(2:0/TXB2)
C25H43O12P (566.2492007999999)
PA(2:0/TXB2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/TXB2), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Thromboxane B2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(TXB2/2:0)
C25H43O12P (566.2492007999999)
PA(TXB2/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(TXB2/2:0), in particular, consists of one chain of one Thromboxane B2 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
(l(-)-tyrosyl)=>glutaminyl=>glutaminyl=>-glutamic acid|(l(-)-Tyrosyl)=>glutaminyl=>glutaminyl=>-glutaminsaeure
(2E)-1-{2,4-dihydroxy-6-methoxy-3-[(2R,4S,6S)-tetrahydro-2-(4-hydroxyphenyl)-6-(2-phenylethyl)-2H-pyran-4-yl]phenyl}-3-(4-hydroxyphenyl)prop-2-en-1-one|Katsumain D
(2E)-1-{(2R,4S)-3,4-dihydro-5-hydroxy-4-[(2S)-2-hydroxy-4-(4-hydroxyphenyl)butyl]-2-(4-hydroxyphenyl)-7-methoxy-2H-1-benzopyran-6-yl}-3-phenylprop-2-en-1-one|katsumain E
(2E)-1-{(2R,4S)-3,4-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-4-[(2S)-2-hydroxy-4-phenylbutyl]-7-methoxy-2H-1-benzopyran-6-yl}-3-(4-hydroxyphenyl)prop-2-en-1-one|katsumain G
(+)-lyoniresinol-3alpha-O-alpha-L-rhamonopyranoside
Asn Tyr Arg Asp
Asn Tyr Asp Arg
Ala Gln Trp Tyr
C28H34N6O7 (566.2488854000001)
Ala Gln Tyr Trp
C28H34N6O7 (566.2488854000001)
Ala Trp Gln Tyr
C28H34N6O7 (566.2488854000001)
Ala Trp Tyr Gln
C28H34N6O7 (566.2488854000001)
Ala Tyr Gln Trp
C28H34N6O7 (566.2488854000001)
Ala Tyr Trp Gln
C28H34N6O7 (566.2488854000001)
Cys Lys Met Trp
Cys Lys Trp Met
Cys Met Lys Trp
Cys Met Trp Lys
Cys Trp Lys Met
Cys Trp Met Lys
Asp Asn Arg Tyr
Asp Asn Tyr Arg
Asp Arg Asn Tyr
Asp Arg Tyr Asn
Asp Tyr Asn Arg
Asp Tyr Arg Asn
Glu Gln Gln Tyr
Glu Gln Tyr Gln
Glu Tyr Gln Gln
Phe His Thr Tyr
C28H34N6O7 (566.2488854000001)
Phe His Tyr Thr
C28H34N6O7 (566.2488854000001)
Phe Asn Thr Trp
C28H34N6O7 (566.2488854000001)
Phe Asn Trp Thr
C28H34N6O7 (566.2488854000001)
Phe Gln Ser Trp
C28H34N6O7 (566.2488854000001)
Phe Gln Trp Ser
C28H34N6O7 (566.2488854000001)
Phe Ser Gln Trp
C28H34N6O7 (566.2488854000001)
Phe Ser Trp Gln
C28H34N6O7 (566.2488854000001)
Phe Thr His Tyr
C28H34N6O7 (566.2488854000001)
Phe Thr Asn Trp
C28H34N6O7 (566.2488854000001)
Phe Thr Trp Asn
C28H34N6O7 (566.2488854000001)
Phe Thr Tyr His
C28H34N6O7 (566.2488854000001)
Phe Trp Asn Thr
C28H34N6O7 (566.2488854000001)
Phe Trp Gln Ser
C28H34N6O7 (566.2488854000001)
Phe Trp Ser Gln
C28H34N6O7 (566.2488854000001)
Phe Trp Thr Asn
C28H34N6O7 (566.2488854000001)
Phe Tyr His Thr
C28H34N6O7 (566.2488854000001)
Phe Tyr Thr His
C28H34N6O7 (566.2488854000001)
His Phe Thr Tyr
C28H34N6O7 (566.2488854000001)
His Phe Tyr Thr
C28H34N6O7 (566.2488854000001)
His His His His
C24H30N12O5 (566.2462009999999)
His Thr Phe Tyr
C28H34N6O7 (566.2488854000001)
His Thr Tyr Phe
C28H34N6O7 (566.2488854000001)
His Tyr Phe Thr
C28H34N6O7 (566.2488854000001)
His Tyr Thr Phe
C28H34N6O7 (566.2488854000001)
Lys Cys Met Trp
Lys Cys Trp Met
Lys Met Cys Trp
Lys Met Trp Cys
Lys Trp Cys Met
Lys Trp Met Cys
Met Cys Lys Trp
Met Cys Trp Lys
Met Lys Cys Trp
Met Lys Trp Cys
Met Trp Cys Lys
Met Trp Lys Cys
Asn Asp Arg Tyr
Asn Asp Tyr Arg
Asn Phe Thr Trp
C28H34N6O7 (566.2488854000001)
Asn Phe Trp Thr
C28H34N6O7 (566.2488854000001)
Asn Arg Asp Tyr
Asn Arg Tyr Asp
Asn Thr Phe Trp
C28H34N6O7 (566.2488854000001)
Asn Thr Trp Phe
C28H34N6O7 (566.2488854000001)
Asn Trp Phe Thr
C28H34N6O7 (566.2488854000001)
Asn Trp Thr Phe
C28H34N6O7 (566.2488854000001)
Gln Ala Trp Tyr
C28H34N6O7 (566.2488854000001)
Gln Ala Tyr Trp
C28H34N6O7 (566.2488854000001)
Gln Glu Gln Tyr
Gln Glu Tyr Gln
Gln Phe Ser Trp
C28H34N6O7 (566.2488854000001)
Gln Phe Trp Ser
C28H34N6O7 (566.2488854000001)
Gln Gln Glu Tyr
Gln Gln Tyr Glu
Gln Ser Phe Trp
C28H34N6O7 (566.2488854000001)
Gln Ser Trp Phe
C28H34N6O7 (566.2488854000001)
Gln Trp Ala Tyr
C28H34N6O7 (566.2488854000001)
Gln Trp Phe Ser
C28H34N6O7 (566.2488854000001)
Gln Trp Ser Phe
C28H34N6O7 (566.2488854000001)
Gln Trp Tyr Ala
C28H34N6O7 (566.2488854000001)
Gln Tyr Ala Trp
C28H34N6O7 (566.2488854000001)
Gln Tyr Glu Gln
Gln Tyr Gln Glu
Gln Tyr Trp Ala
C28H34N6O7 (566.2488854000001)
Arg Asp Asn Tyr
Arg Asp Tyr Asn
Arg Asn Asp Tyr
Arg Asn Tyr Asp
Arg Tyr Asp Asn
Arg Tyr Asn Asp
Ser Phe Gln Trp
C28H34N6O7 (566.2488854000001)
Ser Phe Trp Gln
C28H34N6O7 (566.2488854000001)
Ser Gln Phe Trp
C28H34N6O7 (566.2488854000001)
Ser Gln Trp Phe
C28H34N6O7 (566.2488854000001)
Ser Trp Phe Gln
C28H34N6O7 (566.2488854000001)
Ser Trp Gln Phe
C28H34N6O7 (566.2488854000001)
Thr Phe His Tyr
C28H34N6O7 (566.2488854000001)
Thr Phe Asn Trp
C28H34N6O7 (566.2488854000001)
Thr Phe Trp Asn
C28H34N6O7 (566.2488854000001)
Thr Phe Tyr His
C28H34N6O7 (566.2488854000001)
Thr His Phe Tyr
C28H34N6O7 (566.2488854000001)
Thr His Tyr Phe
C28H34N6O7 (566.2488854000001)
Thr Asn Phe Trp
C28H34N6O7 (566.2488854000001)
Thr Asn Trp Phe
C28H34N6O7 (566.2488854000001)
Thr Trp Phe Asn
C28H34N6O7 (566.2488854000001)
Thr Trp Asn Phe
C28H34N6O7 (566.2488854000001)
Thr Tyr Phe His
C28H34N6O7 (566.2488854000001)
Thr Tyr His Phe
C28H34N6O7 (566.2488854000001)
Trp Ala Gln Tyr
C28H34N6O7 (566.2488854000001)
Trp Ala Tyr Gln
C28H34N6O7 (566.2488854000001)
Trp Cys Lys Met
Trp Cys Met Lys
Trp Phe Asn Thr
C28H34N6O7 (566.2488854000001)
Trp Phe Gln Ser
C28H34N6O7 (566.2488854000001)
Trp Phe Ser Gln
C28H34N6O7 (566.2488854000001)
Trp Phe Thr Asn
C28H34N6O7 (566.2488854000001)
Trp Lys Cys Met
Trp Lys Met Cys
Trp Met Cys Lys
Trp Met Lys Cys
Trp Asn Phe Thr
C28H34N6O7 (566.2488854000001)
Trp Asn Thr Phe
C28H34N6O7 (566.2488854000001)
Trp Gln Ala Tyr
C28H34N6O7 (566.2488854000001)
Trp Gln Phe Ser
C28H34N6O7 (566.2488854000001)
Trp Gln Ser Phe
C28H34N6O7 (566.2488854000001)
Trp Gln Tyr Ala
C28H34N6O7 (566.2488854000001)
Trp Ser Phe Gln
C28H34N6O7 (566.2488854000001)
Trp Ser Gln Phe
C28H34N6O7 (566.2488854000001)
Trp Thr Phe Asn
C28H34N6O7 (566.2488854000001)
Trp Thr Asn Phe
C28H34N6O7 (566.2488854000001)
Trp Tyr Ala Gln
C28H34N6O7 (566.2488854000001)
Trp Tyr Gln Ala
C28H34N6O7 (566.2488854000001)
Tyr Ala Gln Trp
C28H34N6O7 (566.2488854000001)
Tyr Ala Trp Gln
C28H34N6O7 (566.2488854000001)
Tyr Asp Asn Arg
Tyr Asp Arg Asn
Tyr Glu Gln Gln
Tyr Phe His Thr
C28H34N6O7 (566.2488854000001)
Tyr Phe Thr His
C28H34N6O7 (566.2488854000001)
Tyr His Phe Thr
C28H34N6O7 (566.2488854000001)
Tyr His Thr Phe
C28H34N6O7 (566.2488854000001)
Tyr Asn Asp Arg
Tyr Asn Arg Asp
Tyr Gln Ala Trp
C28H34N6O7 (566.2488854000001)
Tyr Gln Glu Gln
Tyr Gln Gln Glu
Tyr Gln Trp Ala
C28H34N6O7 (566.2488854000001)
Tyr Arg Asp Asn
Tyr Arg Asn Asp
Tyr Thr Phe His
C28H34N6O7 (566.2488854000001)
Tyr Thr His Phe
C28H34N6O7 (566.2488854000001)
Tyr Trp Ala Gln
C28H34N6O7 (566.2488854000001)
Tyr Trp Gln Ala
C28H34N6O7 (566.2488854000001)
ethyl 3-(2-(((4-(ethoxy(imino)methyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride
[2-hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
C25H43O12P (566.2492007999999)